BE878603A - Dispositif d'inhalation avec systeme d'ouverture de gelule - Google Patents

Dispositif d'inhalation avec systeme d'ouverture de gelule

Info

Publication number
BE878603A
BE878603A BE0/197015A BE197015A BE878603A BE 878603 A BE878603 A BE 878603A BE 0/197015 A BE0/197015 A BE 0/197015A BE 197015 A BE197015 A BE 197015A BE 878603 A BE878603 A BE 878603A
Authority
BE
Belgium
Prior art keywords
inhalation device
opening system
capsule opening
capsule
inhalation
Prior art date
Application number
BE0/197015A
Other languages
English (en)
Inventor
B Poulsen
Original Assignee
Syntex Puerto Rico Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Puerto Rico Inc filed Critical Syntex Puerto Rico Inc
Publication of BE878603A publication Critical patent/BE878603A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0031—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up by bursting or breaking the package, i.e. without cutting or piercing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S215/00—Bottles and jars
    • Y10S215/03—Medical
BE0/197015A 1978-09-05 1979-09-05 Dispositif d'inhalation avec systeme d'ouverture de gelule BE878603A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/939,614 US4192309A (en) 1978-09-05 1978-09-05 Inhalation device with capsule opener

Publications (1)

Publication Number Publication Date
BE878603A true BE878603A (fr) 1980-03-05

Family

ID=25473463

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/197015A BE878603A (fr) 1978-09-05 1979-09-05 Dispositif d'inhalation avec systeme d'ouverture de gelule

Country Status (8)

Country Link
US (1) US4192309A (fr)
BE (1) BE878603A (fr)
BR (1) BR5901187U (fr)
DE (1) DE7924612U1 (fr)
ES (1) ES245395Y (fr)
FR (1) FR2435255A1 (fr)
IT (1) IT7953540V0 (fr)
ZA (1) ZA794697B (fr)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1598053A (en) * 1978-01-31 1981-09-16 Fisons Ltd Pocket inhaler
US4262666A (en) * 1979-10-24 1981-04-21 Nelson Byron G Inhalator-breathing apparatus
NL8020393A (fr) * 1979-10-30 1981-09-01 Riker Laboratories, Inc. Te Loughborough, Groot-Brittannie.
US4261354A (en) * 1979-11-26 1981-04-14 Nelson Byron G Inhalator-breathing apparatus
US4570630A (en) * 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
US4655231A (en) * 1984-01-09 1987-04-07 Advanced Tobacco Products, Inc. Snuff and preparation thereof
JPS63143081A (ja) * 1986-12-05 1988-06-15 メクト株式会社 吸入器
US5161524A (en) * 1991-08-02 1992-11-10 Glaxo Inc. Dosage inhalator with air flow velocity regulating means
US5469843A (en) * 1991-11-12 1995-11-28 Minnesota Mining And Manufacturing Company Inhalation device
US5305658A (en) * 1992-07-01 1994-04-26 Sterling Winthrop Inc. Capsule transfer device
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
NZ262807A (en) * 1993-03-03 1997-11-24 Glaxo Wellcome Inc Inhalator; medicament carrier for dry powder inhalator has a portion with a plurality of interstices, for a predetermined dose
WO1994023772A2 (fr) * 1993-04-06 1994-10-27 Minnesota Mining And Manufacturing Company Desagglomerants pour inhalateurs a poudre seche
US5388572A (en) * 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5388573A (en) * 1993-12-02 1995-02-14 Tenax Corporation Dry powder inhalator medicament carrier
PT101450B (pt) * 1994-02-02 1999-11-30 Hovione Produtos Farmaceuticos Novo dispositivo para inalacao
EP0759939B1 (fr) * 1994-05-18 2005-07-20 Nektar Therapeutics Procedes et compositions pour produire des interferons sous forme de poudre seche
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
SE9502800D0 (sv) * 1995-08-10 1995-08-10 Astra Ab Disposable inhaler
US5669378A (en) * 1995-12-21 1997-09-23 Pera; Ivo Inhaling device
US20030203036A1 (en) * 2000-03-17 2003-10-30 Gordon Marc S. Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
US20030035778A1 (en) * 1997-07-14 2003-02-20 Robert Platz Methods and compositions for the dry powder formulation of interferon
DE19835346A1 (de) * 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
AU2001283546A1 (en) 2000-08-14 2002-02-25 Advanced Inhalation Research, Inc. Inhalation device and method
US6766799B2 (en) 2001-04-16 2004-07-27 Advanced Inhalation Research, Inc. Inhalation device
WO2003078448A1 (fr) 2002-03-13 2003-09-25 Signum Biosciences, Inc. Modulation de la methylation de proteines et du phosphate des phosphoproteines
US20060045849A1 (en) * 2004-08-24 2006-03-02 Farhan Taghizadeh Method of customizing the fragrance of nasal medications
DE102005001332A1 (de) * 2005-01-11 2006-07-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Zweiteilige Kapsel mit Vorverschluss zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
US8221804B2 (en) * 2005-02-03 2012-07-17 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
US9345745B2 (en) 2005-04-29 2016-05-24 Bo Wang Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides
WO2007052154A2 (fr) * 2005-04-29 2007-05-10 University Of Medicine And Dentistry Of New Jersey Peptide court derive d'erythropoietine et ses mimetiques utilises comme modulateurs immuno / inflammatoires
US9585932B2 (en) 2005-04-29 2017-03-07 Peter C. Dowling Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders
WO2007024876A2 (fr) * 2005-08-24 2007-03-01 The Board Of Trustees Of Leland Stanford Junior University Methodes de traitement et de surveillance de l'inflammation et du desequilibre d'oxydoreduction dans la mucoviscidose
US20090192227A1 (en) * 2005-08-24 2009-07-30 Rabindra Tirouvanziam N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease
US8227408B2 (en) * 2005-09-07 2012-07-24 Neurotez, Inc. Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
CA2898230C (fr) 2007-01-10 2018-04-24 Purdue Research Foundation Inhibiteurs polypeptidiques de la hsp27 kinase et leurs utilisations
US9034815B2 (en) * 2007-01-10 2015-05-19 Moerae Matrix, Inc Polypeptide for treating or preventing adhesions
WO2008156586A2 (fr) * 2007-06-12 2008-12-24 Alkermes, Inc. Perfectionnements à des dispositifs inhalateurs de poudre
DK2185698T3 (en) 2007-08-07 2015-07-27 Purdue Research Foundation Kinase Inhibitors and Uses thereof
WO2009143380A2 (fr) * 2008-05-21 2009-11-26 Neurotez, Inc. Procédés de traitement de troubles cognitifs progressifs liés à la dégénérescence neurofibrillaire
CA2742600A1 (fr) * 2008-11-04 2010-05-14 Nikolaos Tezapsidis Compositions a base de leptine et methodes de traitement de troubles evolutifs de la fonction cognitive provoques par une accumulation d'enchevetrements neurofibrillaires et de beta-amyloide
WO2010068692A1 (fr) * 2008-12-10 2010-06-17 Purdue Research Foundation Inhibiteur perméant cellulaire de kinases à base peptidique
WO2011011721A2 (fr) 2009-07-24 2011-01-27 Amazentis Sa Composés, compositions et méthodes de protection de la santé du cerveau en cas de troubles neurodégénératifs
US9890195B2 (en) 2009-07-27 2018-02-13 Purdue Research Foundation MK2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
CA2832910C (fr) 2011-04-12 2019-07-02 Cynthia Lander Compositions et methodes de prevention ou de traitement de maladies, d'affections ou de processus caracterises par une proliferation aberrante des fibroblastes et un depot de matrice extracellulaire
US9890200B2 (en) 2011-04-12 2018-02-13 Moerae Matrix, Inc. Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
EP2701712B1 (fr) 2011-04-25 2017-06-21 Cornell University Utilisation d'uridine et de désoxyuridine pour traiter les pathologies répondant aux folates
EP2589381B1 (fr) 2011-11-04 2016-08-31 Rabindra Tirouvanziam Compositions pour améliorer ou préserver une fonction de poumons chez un patient souffrant de troubles pulmonaires
WO2013134636A1 (fr) 2012-03-09 2013-09-12 Purdue Research Foundation Compositions et procédés d'administration de peptides inhibiteurs de kinases
CN105025904A (zh) 2012-09-04 2015-11-04 埃莱森制药有限责任公司 用顺铂脂质复合物预防癌症的肺部复发
EP3044218B1 (fr) 2013-09-10 2020-05-27 Board Of Regents Of the University Of Texas System Thérapie ciblant des protéines polypose adénomateuse familiale (apc) tronquées
US10336788B2 (en) 2014-04-17 2019-07-02 Moerae Matrix, Inc. Inhibition of cardiac fibrosis in myocardial infarction
US10082496B2 (en) 2014-09-10 2018-09-25 Board Of Regents Of The University Of Texas System Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
CA2967621A1 (fr) 2014-11-17 2016-05-26 Moerae Matrix, Inc. Compositions et procedes pour prevenir ou traiter des maladies, affections ou processus caracterises par une proliferation aberrante des fibroblastes et un depot de matrice extracellulaire
ES2796973T3 (es) 2014-12-10 2020-11-30 Hyperstem Sa Métodos y composiciones para reducir el crecimiento, la migración y la invasividad de células madre de cáncer cerebral y mejorar la supervivencia de pacientes con tumores cerebrales
AU2016205125A1 (en) 2015-01-08 2017-07-13 Moerae Matrix, Inc. Formulation of MK2 inhibitor peptides
JP2018512401A (ja) 2015-03-12 2018-05-17 モイライ マトリックス インコーポレイテッド Ｍｋ２阻害剤ペプチド含有組成物を用いた非小細胞肺癌の治療を目的とするその使用
US9937154B2 (en) 2015-06-10 2018-04-10 Hackensak University Medical Center Use of telmisartan to prevent and treat graft versus host disease and other alloimmune and autoimmune diseases
CN107949279A (zh) 2015-07-06 2018-04-20 得克萨斯系统大学评议会 可用作用于治疗人类癌症的抗癌剂的苯甲酰胺或苯扎明化合物
AU2016292779B2 (en) 2015-07-15 2021-05-20 The Board Of Regents Of The University Of Texas System Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
AU2017210319A1 (en) 2016-01-20 2018-08-23 Flurry Powders, Llc Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
US11833118B2 (en) 2016-01-20 2023-12-05 Flurry Powders, Llc Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2587215A (en) * 1949-04-27 1952-02-26 Frank P Priestly Inhalator
US2655259A (en) * 1949-11-15 1953-10-13 Davoren William Francis Tablet container
GB1459426A (en) * 1973-02-26 1976-12-22 Allen & Hanburys Ltd Inhalation devices
US4005711A (en) * 1975-01-13 1977-02-01 Syntex Puerto Rico, Inc. Inhalation device

Also Published As

Publication number Publication date
BR5901187U (pt) 1980-06-17
ES245395U (es) 1979-12-16
US4192309A (en) 1980-03-11
IT7953540V0 (it) 1979-08-29
FR2435255A1 (fr) 1980-04-04
DE7924612U1 (de) 1979-11-29
ZA794697B (en) 1981-04-29
ES245395Y (es) 1980-06-16

Similar Documents

Publication Publication Date Title
BE878603A (fr) Dispositif d'inhalation avec systeme d'ouverture de gelule
BE878602A (fr) Dispositif d'inhalation
FR2428763B1 (fr) Dispositif d'accouplement
BE865806R (fr) Dispositif pour l'inhalation de medicament
FR2411447B1 (fr) Dispositif de rotation d'image
FR2538434B1 (fr) Lucarne de couverture avec dispositif d'etancheite
FR2413544B1 (fr) Dispositif perfectionne de retenue d'aubes
FR2525304B1 (fr) Dispositif de securite d'antidevissage
FR2412033B1 (fr) Dispositif d'allumage
FR2518678B1 (fr) Dispositif d'embrayage
FR2349096A1 (fr) Dispositif de raccordement d'appareils medicaux
BE873601A (fr) Dispositif d'accouplement
BE861810A (fr) Dispositif d'assemblage de deux pieces
BE862959A (fr) Dispositif d'etancheite
BE863502A (fr) Dispositif d'ouverture de sacs
FR2544424B1 (fr) Dispositif d'accouplement
BE869242A (fr) Obus fumigene d'exercice
BE875822A (fr) Dispositif de recouvrement de conteneur
BE864881A (fr) Dispositif d'assemblage
BE866537A (fr) Dispositif d'inhalation
BE878476A (fr) Dispositif de perfusion
BE853572A (fr) Dispositif d'obturation de securite
FR2608438B1 (fr) Dispositif de lutte contre l'incendie
RO84358A (fr) Cigarette avec dispositif d'allumage
BE873539R (fr) Dispositif d'etancheite